FDA Will Probe Diabetes Drug Safety Risk Report

Law360, New York (March 14, 2013, 4:48 PM EDT) -- The U.S. Food and Drug Administration said Thursday that it would investigate a new report claiming a class of diabetes drugs, including ones manufactured by drug giants such as Merck & Co. Inc., Bristol-Myers Squibb Co. and AstraZeneca PLC, may cause precancerous changes in the pancreas.

The FDA said that it would evaluate unpublished new findings by a group of academic researchers that suggest a class of Type 2 diabetes drugs called incretin mimetics may lead to an increased risk of pancreatitis and precancerous cellular changes...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.